{"name": "Aerie Pharmaceuticals",
 "permalink": "aerie-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/aerie-pharmaceuticals",
 "homepage_url": "http://www.aeriepharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@aeriepharma.com",
 "phone_number": "908-685-0069",
 "description": "",
 "created_at": "Fri Mar 04 04:43:56 UTC 2011",
 "updated_at": "Sun Apr 07 06:53:01 UTC 2013",
 "overview": "\u003Cp\u003EAerie Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. It focuses on the development of products for the pharmaceutical treatment of glaucoma. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[93,
       122],
      "assets/images/resized/0012/4935/124935v1-max-150x150.png"],
     [[93,
       122],
      "assets/images/resized/0012/4935/124935v1-max-250x250.png"],
     [[93,
       122],
      "assets/images/resized/0012/4935/124935v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Thomas",
      "last_name": "J. van Haarlem",
      "permalink": "thomas-j-van-haarlem",
      "image": null}},
   {"is_past": false,
    "title": "Chief Research Officer and Co-Founder",
    "person":
     {"first_name": "Casey",
      "last_name": "C. Kopczynski",
      "permalink": "casey-c-kopczynski",
      "image": null}},
   {"is_past": false,
    "title": "Vice-President, Chemistry R\u0026D",
    "person":
     {"first_name": "Mitchell",
      "last_name": "deLong",
      "permalink": "mitchell-delong",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$30M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.aeriepharma.com/20110307_pressrelease.html",
    "source_description": "Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 3,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TPG Biotech",
         "permalink": "tpg-biotech",
         "image":
          {"available_sizes":
            [[[150,
               89],
              "assets/images/resized/0011/4964/114964v1-max-150x150.png"],
             [[234,
               139],
              "assets/images/resized/0011/4964/114964v1-max-250x250.png"],
             [[234,
               139],
              "assets/images/resized/0011/4964/114964v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "135 US Highway 206",
    "address2": "Suite 15",
    "zip_code": "07921",
    "city": "Bedminster",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        124],
       "assets/images/resized/0012/4987/124987v1-max-150x150.jpg"],
      [[250,
        207],
       "assets/images/resized/0012/4987/124987v1-max-250x250.jpg"],
      [[450,
        373],
       "assets/images/resized/0012/4987/124987v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}